Enovis CORP financial data

Symbol
ENOV on NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
2711 Centerville Road, Suite 400, Wilmington, DE
State of incorporation
DE
Fiscal year end
December 31
Former names
Colfax CORP (to 3/18/2022)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 225 % +8.36%
Quick Ratio 116 % +5.1%
Debt-to-equity 57.2 % +117%
Return On Equity -3.57 % -64.5%
Return On Assets -2.27 % -32%
Operating Margin -5.83 % -9.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55.9M shares +2.35%
Common Stock, Shares, Outstanding 55.9M shares +2.38%
Entity Public Float 3.48B USD +29.6%
Common Stock, Value, Issued 56K USD +1.82%
Weighted Average Number of Shares Outstanding, Basic 55.7M shares +2.05%
Weighted Average Number of Shares Outstanding, Diluted 55.7M shares +2.05%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.02B USD +16.4%
Revenue from Contract with Customer, Excluding Assessed Tax 2B USD +20.5%
Research and Development Expense 85.7M USD +19.4%
Operating Income (Loss) -117M USD -32.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -142M USD -83%
Income Tax Expense (Benefit) -20.8M USD -160%
Net Income (Loss) Attributable to Parent -119M USD -59.3%
Earnings Per Share, Basic -2.19 USD/shares -59.9%
Earnings Per Share, Diluted -2.19 USD/shares -59.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 35.4M USD +10.3%
Accounts Receivable, after Allowance for Credit Loss, Current 400M USD +44.5%
Inventory, Net 610M USD +29.5%
Other Assets, Current 112M USD +148%
Assets, Current 1.2B USD +40.8%
Property, Plant and Equipment, Net 403M USD +55%
Operating Lease, Right-of-Use Asset 63.4M USD -0.16%
Intangible Assets, Net (Excluding Goodwill) 1.4B USD +26.8%
Goodwill 2.39B USD +18.1%
Other Assets, Noncurrent 90.3M USD -4.87%
Assets 5.55B USD +26.1%
Accounts Payable, Current 158M USD +26.4%
Employee-related Liabilities, Current 87.3M USD +35.5%
Accrued Liabilities, Current 352M USD +53%
Liabilities, Current 530M USD +49.2%
Other Liabilities, Noncurrent 314M USD +96.4%
Liabilities 2.22B USD +131%
Accumulated Other Comprehensive Income (Loss), Net of Tax -55M USD -3.85%
Retained Earnings (Accumulated Deficit) 420M USD -22.1%
Stockholders' Equity Attributable to Parent 3.33B USD -3.18%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 3.33B USD -3.15%
Liabilities and Equity 5.55B USD +26.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -36.2M USD -585%
Net Cash Provided by (Used in) Financing Activities 865M USD +3429%
Net Cash Provided by (Used in) Investing Activities -798M USD -2220%
Common Stock, Shares Authorized 133M shares 0%
Common Stock, Shares, Issued 55.9M shares +2.38%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 29.7M USD
Deferred Tax Assets, Valuation Allowance 102M USD +8.67%
Operating Lease, Liability 66.2M USD -4.62%
Payments to Acquire Property, Plant, and Equipment 36.9M USD +21.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -121M USD -989%
Lessee, Operating Lease, Liability, to be Paid 71.7M USD -5.56%
Property, Plant and Equipment, Gross 513M USD +22.8%
Operating Lease, Liability, Current 6.82M USD +90.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.4M USD +7.04%
Lessee, Operating Lease, Liability, to be Paid, Year One 19.5M USD -12.6%
Deferred Income Tax Expense (Benefit) -9.97M USD -1299%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.51M USD -15.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.4M USD +6.43%
Deferred Tax Assets, Operating Loss Carryforwards 37.4M USD -1.39%
Unrecognized Tax Benefits 32.1M USD -16.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.4M USD -18.6%
Additional Paid in Capital 2.96B USD +0.41%
Amortization of Intangible Assets 160M USD +23.1%
Depreciation, Depletion and Amortization 6.43M USD -15.4%
Deferred Tax Assets, Net of Valuation Allowance 227M USD +2.25%
Share-based Payment Arrangement, Expense 29.8M USD -12.1%
Interest Expense 52.3M USD +142%